{
    "nctId": "NCT05990478",
    "briefTitle": "A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer",
    "officialTitle": "Contrast-Enhanced Mammography With Early and Delayed Acquisitions in the Assessment of the Extent of Residual Disease Following Neoadjuvant Treatment in Patients With Breast Cancer",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Compare the sensitivity and specificity of Contrast-Enhanced Mammography/CEM with standard 'early' acquisition to CEM with delayed acquisition",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Any women \\>18 years of age at time of informed consent\n* Diagnosed with breast cancer and schedule for NAT\n\nExclusion Criteria:\n\n* History of kidney disease, creatinine level \\>1.3 or eGFR \\<45.\n* Known allergic reaction to gadolinium or iodinated contrast media.\n* Contraindication to contrast-enhanced breast MRI.\n* Lesion not included in the field of view of either pre- or post-NAT MRI or CEM\n* Presence of pacemakers or automated implantable cardioverter defibrilator\n* Pregnant women",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}